Odyssey Health, Inc. (OTCMKTS:ODYY) Stock Short Interest Report for October

Odyssey Health, Inc. (OTCMKTS:ODYY) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 29,561 shares, a decline of 50.8% from the September 30th total of 60,061 shares. Based on an average daily trading volume, of 40,904 shares, the days-to-cover ratio is currently 0.7 days.

Odyssey Health Stock Performance

Shares of ODYY stock traded up $0.00 on Friday, hitting $0.01. 1,705,351 shares of the stock traded hands, compared to its average volume of 169,815. The company’s fifty day moving average is $0.01 and its 200 day moving average is $0.03. Odyssey Health has a 1-year low of $0.00 and a 1-year high of $0.08.

Odyssey Health Company Profile

Odyssey Health, Inc, formerly known as Odyssey Group International, Inc, is a medical technology and pharmaceutical development company focused on products for neurological and other serious health conditions. The company’s work includes drug candidates and medical devices intended to address unmet needs in brain health.

Odyssey Health’s principal development program is ONP-002, an intranasal drug candidate being developed for the treatment of concussion and traumatic brain injury. The company has stated that the product is designed to deliver treatment directly to the brain through the nasal passage and may help address the effects of brain injury.